Codexis, Inc. CDXS 深 滬
已收盤 05-08 16:00:00 美东时间
2.85
+0.270
+10.47%
華盛通- 最 高2.9198
- 今 開2.60
- 成交量 182.62万股
- 最 低 2.56
- 昨 收 2.58
- 總市值 2.59亿
- 52周最高 3.87
- 市盈率 靜 --
- 換手率 2.01%
- 52周最低 0.9583
- 委 比 -49.99%
- 總股本 9089.66万
- 歷史最高 42.01
- 量 比 1.29
- 振 幅 13.95%
- 歷史最低 0.9583
- 每 手 1
- 風險率 0.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多电话会总结 ｜ Codexis(CDXS)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Codexis业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度总收入达1,520万美元，较2025年同期的750万美元实现翻倍增长，主要得益于与默克公司技术转让协议的收入确认。 **盈利能力：** 产品毛利率为71%，较去年同期的55%显著提升，主要由于产品组合优化和低毛利率产品销售的减少。净亏损为870万美元，较2025年同期的2,070万美元大幅收窄。 **成本控制：** 研发费用为1,140万美元，较去年同期的1,290万美元下降；销售、一般及行政费用为980万美元，较去年同期的1,240万
05-09 12:26
Codexis Affirms FY2026 Sales Guidance of $72.000M-$76.000M vs $74.234M Est
Codexis (NASDAQ:CDXS) affirms FY2026 sales outlook from $72.000 million-$76.000 million to $72.000 million-$76.000 million vs $74.234 million estimate.
05-08 04:38
Codexis Q1 EPS $(0.10) Beats $(0.14) Estimate, Sales $15.248M Beat $14.525M Estimate
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 60 percent increase over losses of $(0.25) per share from the same
05-08 04:37
Codexis To Present New Data And Provide Regulatory Update On ECO Synthesis Manufacturing Platform At TIDES USA May 11-14
Codexis' technical experts will present at three sessions during the conference:Spotlight Presentation:Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in Oligonucleotide ManufacturingStefan Lutz,
04-29 21:03
美股牛股 | Lightwave飙升41%，与Tower半导体合作，推进电光聚合器技术商业化；塞拉尼斯大涨14%
Lightwave飙升41%，与Tower半导体合作，推进电光聚合器技术商业化；WOOF大涨34%，财报超预期获机构上调评级；塞拉尼斯大涨14%，霍尔木兹海峡持续封锁催高公司产品价格>>
03-13 15:45
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth quarter and full-year 2025 revenue growth.
03-12 13:25
Codexis shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance above estimates.
Codexis shares are trading higher after the company reported better-than-expect...
03-12 04:17
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Preview: Codexis's Earnings
Codexis (NASDAQ:CDXS) is preparing to release its quarterly earnings on Wednesd...
03-11 01:01
Codexis Inks Deal With Pharmaceutical Firm To Manufacture siRNA Material
Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with an innovator pharmaceutical company to
03-04 23:08
